Patient P-01876
Synthetic patientNBL-101 · Day 118 · 25–34 · M · baseline S19Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
16%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S19
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+7
- Inflammatory activity+7
- Treatment adherence-7
- Nutritional resilience-3
- Toxicity+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion7.4/100
worsening · +0.2 vs previous 14 d
Toxicity
Blood14.1/100
worsening · +3.4 vs previous 14 d
Sleep quality
Wearable76.1/100
worsening · -5.3 vs previous 14 d
Energy level
Daily log7.6/10
stable · +0.1 vs previous 14 d
Stress level
Daily log2.1/10
worsening · +0.2 vs previous 14 d
Steps
Wearable4,676
stable · -140 vs previous 14 d
Adherence
Companion89.4 %
stable · -2.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 99 from the failing basin, 13 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Insoluble fibre-2.3no signal · 45%
- Histamine load-0.4no signal · 15%
- Dietary fat load-0.2no signal · 15%
- Simple carbohydrates-0.2no signal · 15%
- Alcohol+0.2no signal · 15%
- Spicy / capsaicin0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3 · butyrate capacity 57/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 75 ms
- Sleep
- 7.9 h
- Steps
- 5,501
- Resting HR
- 66 bpm
Daily log: GI score 7, nutritional resilience 72, adherence 89.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.